EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis

See Young Lee, Ye-Chan Park, Jaesun Cha, Youngmi Song, Ji Hae Nahm, Jae Hee Cho, Jung Hyun Jo, Chan Min Jung, Su Yun Lee, Chae Eun Jang, Sungsoon Fang, Sung Ill Jang

Cancers · 18.11.2026 · 18 (22) · 3686

DOI: 10.3390/cancers18223686 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 18.11.2026. Verfasst von See Young Lee und 11 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Yonsei University College of Medicine, Kangbuk Samsung Hospital.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cholangiocarcinoma (CCA) has a poor prognosis, and drugs that are effective in subcutaneous xenograft models frequently fail to show clinical benefit. The role of the implantation site in this translational gap remains unclear.

Methods

We established intrahepatic orthotopic and subcutaneous xenograft models using the human SCK CCA cell line in BALB/c nude mice. Tumor development was documented by serial gross observation, and subcutaneous tumor growth was quantified using a caliper. At necropsy, tumors were examined macroscopically and by hematoxylin-and-eosin staining and were subjected to bulk RNA sequencing. Differential expression and gene set enrichment analyses were used to compare signaling and metabolic programs, with cross-reference to The Cancer Genome Atlas-Cholangiocarcinoma (TCGA-CHOL) dataset.

Results

Orthotopic tumors formed intrahepatic masses with additional intra-abdominal nodules, whereas subcutaneous xenografts formed localized dorsal masses without dissemination. Tumor cell morphology was comparable. Transcriptomic profiling showed concordant upregulation of cell cycle pathways but divergent metabolic programs—downregulation of cholesterol and sterol metabolism in orthotopic tumors versus downregulation of lipid and fatty acid catabolism in subcutaneous tumors. The phosphatidylinositol 3 kinase–protein kinase B (PI3K–AKT) signaling pathway was enriched only in orthotopic tumors. Eleven PI3K–AKT pathway genes upregulated in orthotopic tumors were also upregulated in human CCA tissues in the TCGA-CHOL dataset.

Conclusions

Orthotopic and subcutaneous CCA models differ substantially in microenvironment-shaped transcriptional programs. Selective enrichment of PI3K–AKT pathway genes only in orthotopic tumors may explain the discordance between subcutaneous xenograft drug responses and clinical outcomes. Orthotopic implantation may be a more clinically relevant preclinical model.

Förderung

  • National Research Foundation of Korea
  • Yonsei University College of Medicine
  • Kangbuk Samsung Hospital
  • Ministry of Health and Welfare

Zitieren

APA

Lee, S. Y., Park, Y., Cha, J., Song, Y., Nahm, J. H., Cho, J. H., Jo, J. H., Jung, C. M., Lee, S. Y., Jang, C. E., Fang, S., & Jang, S. I. (2026). Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis. Cancers, 18(22), 3686. https://doi.org/10.3390/cancers18223686

Vancouver

Lee SY, Park Y, Cha J, Song Y, Nahm JH, Cho JH, et al. Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis. Cancers. 2026;18(22):3686. doi:10.3390/cancers18223686

BibTeX
@article{Lee2026,
  author = {Lee, See Young and Park, Ye-Chan and Cha, Jaesun and Song, Youngmi and Nahm, Ji Hae and Cho, Jae Hee and Jo, Jung Hyun and Jung, Chan Min and Lee, Su Yun and Jang, Chae Eun and Fang, Sungsoon and Jang, Sung Ill},
  title = {Differential PI3K–AKT Pathway Enrichment Between Orthotopic and Subcutaneous Xenograft Models of Cholangiocarcinoma: A Comparative Transcriptomic and Pathologic Analysis},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {22},
  pages = {3686},
  doi = {10.3390/cancers18223686}
}
Kostenlos starten →